These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 29808375)

  • 41. Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma.
    Tokunaga R; Imamura Y; Nakamura K; Uchihara T; Ishimoto T; Nakagawa S; Iwatsuki M; Baba Y; Sakamoto Y; Miyamoto Y; Yoshida N; Oyama S; Shono T; Naoe H; Saeki H; Oki E; Watanabe M; Sasaki Y; Maehara Y; Baba H
    Cancer Med; 2015 Nov; 4(11):1659-66. PubMed ID: 26310928
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Adenocarcinoma of the esophagogastric junction: retrospective analysis of 39 patients].
    Butte JM; Becker F; Visscher A; Waugh E; Meneses M; Court I; Parada H; DE LA Fuente H
    Rev Med Chil; 2010 Jan; 138(1):53-60. PubMed ID: 20361151
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brain metastases in patients with upper gastrointestinal cancer is associated with proximally located adenocarcinoma and lymph node metastases.
    Harada K; Hwang H; Wang X; Abdelhakeem A; Iwatsuki M; Murphy MAB; Maru DM; Weston B; Lee JH; Rogers JE; Trail A; Shanbhag N; Zhao M; Bhutani MS; Nguyen QN; Swisher SG; Ikoma N; Das P; Hofstetter WL; Badgwell BD; Ajani JA
    Gastric Cancer; 2020 Sep; 23(5):904-912. PubMed ID: 32347396
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Priority of lymph node dissection for Siewert type II/III adenocarcinoma of the esophagogastric junction.
    Hasegawa S; Yoshikawa T; Rino Y; Oshima T; Aoyama T; Hayashi T; Sato T; Yukawa N; Kameda Y; Sasaki T; Ono H; Tsuchida K; Cho H; Kunisaki C; Masuda M; Tsuburaya A
    Ann Surg Oncol; 2013 Dec; 20(13):4252-9. PubMed ID: 23943020
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Multi-Institutional Study Comparing the Use of the American Joint Committee on Cancer 7th Edition Esophageal
    Adeshuko FA; Squires MH; Poultsides G; Pawlik TM; Weber SM; Schmidt C; Votanopoulos K; Fields RC; Maithel SK; Cardona K
    Am Surg; 2017 Jan; 83(1):82-89. PubMed ID: 28234131
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimal treatment for Siewert type II and III adenocarcinoma of the esophagogastric junction: A retrospective cohort study with long-term follow-up.
    Hosoda K; Yamashita K; Moriya H; Mieno H; Watanabe M
    World J Gastroenterol; 2017 Apr; 23(15):2723-2730. PubMed ID: 28487609
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project.
    Sano T; Coit DG; Kim HH; Roviello F; Kassab P; Wittekind C; Yamamoto Y; Ohashi Y
    Gastric Cancer; 2017 Mar; 20(2):217-225. PubMed ID: 26897166
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The superiority of the seventh edition of the TNM classification depends on the overall survival of the patient cohort: comparative analysis of the sixth and seventh TNM editions in patients with gastric cancer from Japan and the United Kingdom.
    Hayashi T; Yoshikawa T; Bonam K; Sue-Ling HM; Taguri M; Morita S; Tsuburaya A; Hayden JD; Grabsch HI
    Cancer; 2013 Apr; 119(7):1330-7. PubMed ID: 23280435
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mediastinal lymph node metastasis and recurrence in adenocarcinoma of the esophagogastric junction.
    Kurokawa Y; Hiki N; Yoshikawa T; Kishi K; Ito Y; Ohi M; Wada N; Takiguchi S; Mine S; Hasegawa S; Matsuda T; Takeuchi H
    Surgery; 2015 Mar; 157(3):551-5. PubMed ID: 25532434
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of the adenocarcinoma of the esophagogastric junction at a single institution in Mexico.
    Oñate-Ocaña LF; Milán-Revollo G; Aiello-Crocifoglio V; Carrillo JF; Gallardo-Rincón D; Brom-Valladares R; Herrera-Goepfert R; Dueñas-González A
    Ann Surg Oncol; 2007 Apr; 14(4):1439-48. PubMed ID: 17235713
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A population-based validation study of the 8th edition UICC/AJCC TNM staging system for cutaneous melanoma.
    Hynes MC; Nguyen P; Groome PA; Asai Y; Mavor ME; Baetz TD; Hanna TP
    BMC Cancer; 2022 Jul; 22(1):720. PubMed ID: 35778691
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of old and new TNM systems for nodal staging in adenocarcinoma of the gastro-oesophageal junction.
    de Manzoni G; Pedrazzani C; Verlato G; Roviello F; Pasini F; Pugliese R; Cordiano C
    Br J Surg; 2004 Mar; 91(3):296-303. PubMed ID: 14991629
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors predicting recurrence in patients with Siewert type II carcinoma treated with curative resection.
    Fukuchi M; Mochiki E; Suzuki O; Ishiguro T; Sobajima J; Onozawa H; Imaizumi H; Shibata K; Saito K; Naitoh H; Kumagai Y; Ishibashi K; Ishida H
    Anticancer Res; 2015 Jan; 35(1):505-9. PubMed ID: 25550595
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the clinicopathological characteristics and the survival outcomes between the Siewert type II/III adenocarcinomas.
    Zhang WH; Chen XZ; Liu K; Anil K; Yang K; Chen JP; Zhou ZG; Hu JK
    Med Oncol; 2014 Aug; 31(8):116. PubMed ID: 25023054
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Survival rate of proximal and total gastrectomy in treatment of esophagogastric junction adenocarcinoma (Siewert II( Types)].
    Nai C; Liu Z; Lian X; Liu S; Guo M; Xiao S; Liu J; Yang X; Zhang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Feb; 19(2):195-9. PubMed ID: 26831885
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Management of Locally Advanced Gastroesophageal Cancer: Still a Multidisciplinary Global Challenge?
    Al-Batran SE; Lorenzen S
    Hematol Oncol Clin North Am; 2017 Jun; 31(3):441-452. PubMed ID: 28501086
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Analysis of survival and prognosis of Siewert Ⅱ/Ⅲ esophagogastric junction adenocarcinoma patients with non-operative acute upper gastrointestinal hemorrhage].
    Tian L; Yu L
    Zhonghua Yi Xue Za Zhi; 2020 Jun; 100(24):1881-1885. PubMed ID: 32575932
    [No Abstract]   [Full Text] [Related]  

  • 58. Proposal of a Nomogram for Predicting Survival in Patients with Siewert Type II Adenocarcinoma of the Esophagogastric Junction After Preoperative Radiation.
    Liu F; Zhou R; Jiang F; Liu G; Li K; Zhu G
    Ann Surg Oncol; 2019 May; 26(5):1292-1300. PubMed ID: 30805805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Staging of adenocarcinoma of the gastroesophageal junction.
    Parry K; Haverkamp L; Bruijnen RC; Siersema PD; Offerhaus GJ; Ruurda JP; van Hillegersberg R
    Eur J Surg Oncol; 2016 Mar; 42(3):400-6. PubMed ID: 26777127
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical diagnosis of adenocarcinoma of the esophago-gastric junction].
    Bîrla R; Iosif C; Gîndea C; Hoară P; Constantinoiu S
    Chirurgia (Bucur); 2007; 102(5):511-20. PubMed ID: 18018349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.